Respiratory Syncytial Virus (RSV) is a contagious virus that can cause infections in the lungs and respiratory tract. There is currently no FDA-approved vaccine for the prevention of RSV.

We are conducting a research study for a new investigational RSV vaccine in adults 60 years or older. This study will be evaluating the safety and effectiveness of an investigational vaccine.

You may be eligible if you:

• Are 60 years or older
• Are healthy (stable medical conditions)

You may not qualify to participate if you:

• Are currently in another research study
• Are immune-compromised
• Have a history of a severe reaction to any prior vaccination

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive all study-related investigational vaccines, procedures, and medical exams at no cost, as well as a stipend for time and travel. No health insurance is required to participate.

For more information call

(904) 730-0166
Or sign up below, and our office will call you!